The Industry Expert in Gene Synthesis Solutions

Similar documents
Recombinant DNA Unit Exam

LabGenius. Technical design notes. The world s most advanced synthetic DNA libraries. hi@labgeni.us V1.5 NOV 15

Description: Molecular Biology Services and DNA Sequencing

Bio-Reagents Gene synthesis Peptide Synthesis Protein Expression Antibody Production. Life Science Products and Services

June 09, 2009 Random Mutagenesis

Integrated Protein Services

Vector NTI Advance 11 Quick Start Guide

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

Integrated Protein Services

European Medicines Agency

KMS-Specialist & Customized Biosimilar Service

From DNA to Protein. Proteins. Chapter 13. Prokaryotes and Eukaryotes. The Path From Genes to Proteins. All proteins consist of polypeptide chains

Biotechnology: DNA Technology & Genomics

How many of you have checked out the web site on protein-dna interactions?

DNA Replication & Protein Synthesis. This isn t a baaaaaaaddd chapter!!!

Expression and Purification of Recombinant Protein in bacteria and Yeast. Presented By: Puspa pandey, Mohit sachdeva & Ming yu

Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company Chapter 8: Recombinant DNA 2002 by W. H. Freeman and Company

2. The number of different kinds of nucleotides present in any DNA molecule is A) four B) six C) two D) three

Introduction to Bioinformatics 3. DNA editing and contig assembly

Genetics Lecture Notes Lectures 1 2

Becker Muscular Dystrophy

Gene Synthesis & Protein Engineering News by DNA2.0 Inc. SEPTEMBER 2005

Molecular Biology. Yeast Transformation. Yeast Plasmids. Gene Disruption, tagging. Cloning by Complementation. Epistasis

Real-Time PCR Vs. Traditional PCR

INDUSTRY OVERVIEW. Our business segments. (ii) Global drug development service market Preclinical drug development services

MUTATION, DNA REPAIR AND CANCER

Translation Study Guide

Genetic Technology. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

RNA & Protein Synthesis

First Strand cdna Synthesis

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

HCS Exercise 1 Dr. Jones Spring Recombinant DNA (Molecular Cloning) exercise:

Difficult DNA Templates Sequencing. Primer Walking Service

Structure and Function of DNA

Recombinant DNA & Genetic Engineering. Tools for Genetic Manipulation

Institutional Partnership Program

restriction enzymes 350 Home R. Ward: Spring 2001

Recombinant DNA Technology

The sequence of bases on the mrna is a code that determines the sequence of amino acids in the polypeptide being synthesized:

Providing Trusted and Innovative Solutions t o the Life Science Communities

Chapter 5: Organization and Expression of Immunoglobulin Genes

Concluding lesson. Student manual. What kind of protein are you? (Basic)

Molecular Genetics. RNA, Transcription, & Protein Synthesis

Genetomic Promototypes

CCR Biology - Chapter 9 Practice Test - Summer 2012

Recombinant DNA and Biotechnology

Bio 102 Practice Problems Recombinant DNA and Biotechnology

Transcription in prokaryotes. Elongation and termination

Focusing on results not data comprehensive data analysis for targeted next generation sequencing

Genetics Test Biology I

Introduction to Proteins and Enzymes

Nucleic Acid Amplification Life Science Dashboard Series 3

Catalent Biologics & Clinical Supplies The SMART Solution

When you install Mascot, it includes a copy of the Swiss-Prot protein database. However, it is almost certain that you and your colleagues will want

SeqScape Software Version 2.5 Comprehensive Analysis Solution for Resequencing Applications

DNA sequencing. Dideoxy-terminating sequencing or Sanger dideoxy sequencing

Genetic information (DNA) determines structure of proteins DNA RNA proteins cell structure enzymes control cell chemistry ( metabolism )

Ms. Campbell Protein Synthesis Practice Questions Regents L.E.

HuCAL Custom Monoclonal Antibodies

Wide range of high-quality enzymes and proteins for molecular biology

Creating Standard Curves with Genomic DNA or Plasmid DNA Templates for Use in Quantitative PCR

Chapter 6 DNA Replication

Algorithms in Computational Biology (236522) spring 2007 Lecture #1

DNA Scissors: Introduction to Restriction Enzymes

INDUSTRY OVERVIEW LIFE SCIENCES RESEARCH PRODUCTS AND SERVICES. Overview

BCOR101 Midterm II Wednesday, October 26, 2005

Genetics Module B, Anchor 3

Name Class Date. Figure Which nucleotide in Figure 13 1 indicates the nucleic acid above is RNA? a. uracil c. cytosine b. guanine d.

Molecular typing of VTEC: from PFGE to NGS-based phylogeny

Bob Jesberg. Boston, MA April 3, 2014

Systematic discovery of regulatory motifs in human promoters and 30 UTRs by comparison of several mammals

Replication Study Guide

Module 3 Questions. 7. Chemotaxis is an example of signal transduction. Explain, with the use of diagrams.

Application Guide... 2

Biotechnology and Recombinant DNA (Chapter 9) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College

DNA (genetic information in genes) RNA (copies of genes) proteins (functional molecules) directionality along the backbone 5 (phosphate) to 3 (OH)

Microarray Technology

Regents Biology REGENTS REVIEW: PROTEIN SYNTHESIS

Recombinant DNA Technology

pcas-guide System Validation in Genome Editing

PrimeSTAR HS DNA Polymerase

Bioinformatics Resources at a Glance

Basic Concepts of DNA, Proteins, Genes and Genomes

Genome Editing TOOLS TO SUPPORT CRISPR/CAS9 APPLICATIONS

Improved methods for site-directed mutagenesis using Gibson Assembly TM Master Mix

pmod2-puro A plasmid containing a synthetic Puromycin resistance gene Catalog # pmod2-puro For research use only Version # 11H29-MM

Genes to Proteins to Antibodies

Advances in RainDance Sequence Enrichment Technology and Applications in Cancer Research. March 17, 2011 Rendez-Vous Séquençage

PRACTICE TEST QUESTIONS

BCH401G Lecture 39 Andres

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

BRCA1 / 2 testing by massive sequencing highlights, shadows or pitfalls?

Hidden Markov Models in Bioinformatics. By Máthé Zoltán Kőrösi Zoltán 2006

Mitochondrial DNA Analysis

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

The Chinese University of Hong Kong igem 2010 Bacterial based storage and encryp2on device

Arabidopsis. A Practical Approach. Edited by ZOE A. WILSON Plant Science Division, School of Biological Sciences, University of Nottingham

STUDIES ON SEED STORAGE PROTEINS OF SOME ECONOMICALLY MINOR PLANTS

New Technologies for Sensitive, Low-Input RNA-Seq. Clontech Laboratories, Inc.

Gene Models & Bed format: What they represent.

Transcription:

The Industry Expert in Gene Synthesis Solutions Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA

Using Synthesis to Build Multi- Site Libraries and Gene Variants to Improve Protein and Antibody Function Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA 2

A Better Way to Discovery Existing tools New methods New technologies

BlueHeron Founded in 1999 to automate labor-intensive reagent production by combining expertise in: Molecular biology Chemistry Informatics 2001 launched GeneMaker Patented multi-technology platforms established Production scale custom gene synthesis services 2007-2010 Gold Standard Industry leader The first company to synthesize and deliver a 52KB gene The primary supplier for the 1st bacterial genome The sole DNA source for the 1st synthetic life by J. Craig Venter Inst.- 1 mega base of DNA synthesized in 1 month 2010 Joined OriGene as a wholly owned subsidiary 4

Goal: Efficient pathway to target discovery Improve Protein Function Improve Antibody Affinity Discover New Targets 5

Site Saturation vs. Directed Evolution Evaluation of Beta-gal activity on a non-native substrate Directed Evolution 7 iterated cycles of DNA shuffling and screening 39-fold increase in non-native activity 1,000-fold improved discrimination Saturation Mutagenesis Saturated 3 residues in active site H540V 225-fold higher activity on non-native ~100,000-fold improved discrimination 6

Problem: What path to take? Method Random mutagenesis Roadblocks Inexpensive but low specificity Methods: error Prone PCR, MutS E. coli strains Recombination Need clones, limited by PCR, limit to mutation loci Method: PCR Shuffling (Stemmer, et al. Maxygen) Degenerate oligonucleotides Creates biased pools Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA 7

Synthesis: A better option New Option Synthetic gene variants Codon optimization Simple base substitutions Amino acid substitutions Variable region substitutions Defined Multi-site libraries Advantages Can introduce changes ANYWHERE Enables ability to encode specific changes (e.g. codonbased) Individual clones received in an expression vector Defined timeline and costs Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA 8

Goal: Efficient pathway to target discovery Improve Protein Function 9

Codon Optimization of Gene Sequence for Protein Expression Submit: Amino Acid Sequence Include or exclude specific DNA motifs Codon Optimization Codon usage match Expression Optimization Secondary RNA structure minimization 10

Goal: Efficient pathway to target discovery Improve Antibody Affinity Discover New Targets 11

Creating Variants Simple Variants SNPs, adding new 5 or 3 tag or promoter Complex Variants Multi-site base changes Amino Acid scans and substitutions (R&D development) Variants for Antibody Research Single Region Variable H/L chain single cassette Dual Region Variable H/L chain swap Variant Libraries- (R&D development) Complex Defined Variant Pooled Libraries Multi-site, close proximity amino acid libraries Dual Region swaps for antibody discovery

Complex Variants Multi-site base changes ATGTCGAGATCGATTAGAGCGCTCGAATCGATAGCTTAG ATGTGGAGCTCGATTAGAGCGCTCCAATCGTTAGCTTAG 13

Varying methods for improving protein function/antibody affinity Structure-based engineering Requires structure and highly detailed models of the proteins function Mutagenesis and screening or selection Error-prone PCR Directed Evolution Mix diversity from a family of native proteins Synthetic Defined Multi-site Libraries 14

Antibody Improvement Site saturation mutagenesis of 67 light and heavy chain CDR amino acids = ~1,350 clones Multi-site library with five best variants Best multi-site clone had two changes, 40-fold higher affinity Neutralized at an 8-fold lower concentration of antibody 15

Amino Acid Substitutions Non-complex MTGPAGCTPTLLACPCGSCULCSLTPATRLCSTLPACGGPLGC Amino Acid Substitution: Alanine Cystein Moderately-Complex MTGPAGCTPTLLACPCGSCULCSLTPATRLCSTLPACGGPLGC Replace each with given number of amino acids (19, 10, 5, etc.) Complex- R&D Technology Development MTGPAVCTPTLLACPCGSCULCSLTPATRLCSTLPACGGPLGC 16

SINGLE REGION VARIANTS Fast and economical antibody optimization and design Figure 1: Define/Design the Variable Region -Modify amino acid sequence -Modify nucleotide sequence -Scalable Projects make a few to hundreds of variants Figure 2: Newly Synthesized Plasmid -New Variable Regions will be inserted as requested to form the final plasmid ready for expression or screening -Backbone vector can be a Customerprovided expression vector -Delivered as individual, sequence verified clones Figure 1: Figure 2: Constant Region 1 Variable Region Constant Region 2 Constant Region 1 Starter Construct Variant 1 Constant Region 2 Constant Region 1 Variant 2 Constant Region 2 Constant Region 1 Variant 3 Constant Region 2 Constant Region 1 Variant 4 Constant Region 2 Variants Constant Region 1 New Vector Containing Constant Region(s) Constant Region 2 Applications: Antibody Screening Variant Screening Benefits: Design Freedom Economical Solution Fast Turnaround Variant 1 Variant 2 Variant 3 Variant 4 Your variants in the New Vector containing constant region(s) 17

BlueHeron Biotech- Synthesis Application: Multi-site Defined Mutagenesis Figure 1: Choose the Amino Acid positions to replace or choose full saturation Figure 2/3: Each amino acid will be replaced synthetically Delivered as individual, sequence verified clones or pooled groups Advantages: -Define 1 to 19 amino acids at single or multiple positions -Sequence verified as individual clones -Equal representation as pooled groups -Ability to further define position changes downstream using an existing template for synthesis -Fast (4-6 weeks) -Economical Figure 1: Wild Type ALA ALA ALA ALA ALA Figure 2: Single amino acid changes Cys Cys Cys Cys Cys Figure 3: Multiple amino acid changes per location: ASAKVSCKASGYTFTCSVTAAPQVSAAVSTTLVLQP ASLKVSCKASGYTFTCLVTAAPQVSAAVSTLLVLQP ASCKVSCKASGYTFTCCVTAAPQVSAAVSTCLVLQP ASGKVSCKASGYTFTCGVTAAPQVSAAVSTGLVLQP ASKKVSCKASGYTFTCKVTAAPQVSAAVSTTKVLQP ASTKVSCKASGYTFTCTVTAAPQVSAAVSTTTVLQP.. 18

Dual Region Swaps Parts- Synthesized individually Codon Optimize synthesized fragments. Synthesize with linkers, tags, promoter regions. Assemble in various configurations Blue Heron Bio adds synthetic ends to allow for cassette assembly Clone into customer-provided vector or BHB standard vector Delivered as individual clonessequence verified Variant Region 1 Variant Region 2 Variant Region 3 Variant Region 4 Fragments assembled in various configurations Variant Region 1 Variant Region 2 Variant Region 3 Variant Region 4 Variant Region 1 Variant Region 4 Variant Region 2 Variant Region 3 19

Defined Multi-site Libraries Choose 50-300 amino acid positions in your protein Blue Heron delivers a library: 16-19 clones for each position Customer defines number of amino acid or codon substitutions at each position Example- 950 clones for a 50 position library Each is cloned and sequence-verified 20

Advantages of Using synthesis to create a multi-site library Minimize the number of assays No need for 10X coverage to ensure that you assay each variant once Maximize the value of the information Assay in triplicate Optimize the time to results High quality clones + reproducible assays = high quality data 21

Timeline to Protein Improvement Defined Saturation Mutagenesis Perform Assays, analyze data Multi-Site Library Assay, choose best protein Blue Heron 6-8 weeks 4-6 weeks Customer 2-4 weeks 2-4 weeks Improved protein in 3-5 months Predictable cost and well-defined results 22

Well-Defined Path to Improvement Small and well-defined number of highlyinformative assays Crisp decision points Single change improves the activity? Multi-site results positive? Predictable costs and timeline If a protein is worth your scientists time and effort, isn t it worth doing the definitive experiment? Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA 23

Blue Heron Biotech,LLC- a wholly owned subsidiary of OriGene Technologies, Inc. www.blueheronbio.com Bothell, WA USA 24